Pharmedic Pharmaceutical Medicinal Share Price

Equities

PMC

VN000000PMC3

Pharmaceuticals

End-of-day quote HANOI S.E. 23:00:00 21/05/2024 BST 5-day change 1st Jan Change
87,400 VND +0.34% Intraday chart for Pharmedic Pharmaceutical Medicinal +9.25% +1.51%

Financials

Sales 2022 472B 18.42M 1.46B Sales 2023 485B 18.92M 1.5B Capitalization 804B 31.34M 2.48B
Net income 2022 83.42B 3.25M 258M Net income 2023 83.56B 3.26M 258M EV / Sales 2022 1.06 x
Net cash position 2022 294B 11.45M 906M Net cash position 2023 262B 10.23M 810M EV / Sales 2023 1.12 x
P/E ratio 2022
13 x
P/E ratio 2023
13.2 x
Employees 534
Yield 2022
3.53%
Yield 2023
17.4%
Free-Float 55.83%
More Fundamentals * Assessed data
Dynamic Chart
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Saigon - Hanoi Securities Joint Stock Company acquired additional 5.9% minority stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company (HNX : PMC). CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Pharmedic Pharmaceutical Medicinal Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
More news
1 day+0.34%
1 week+9.25%
Current month+7.90%
1 month+6.72%
3 months+7.90%
6 months+6.59%
Current year+1.51%
More quotes
1 week
81 000.00
Extreme 81000
88 900.00
1 month
74 300.00
Extreme 74300
88 900.00
Current year
73 600.00
Extreme 73600
88 900.00
1 year
63 000.00
Extreme 63000
93 000.00
3 years
59 000.00
Extreme 59000
93 000.00
5 years
36 100.00
Extreme 36100
93 000.00
10 years
36 100.00
Extreme 36100
102 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 -
Chief Tech/Sci/R&D Officer 54 -
Director/Board Member 62 -
Members of the board TitleAgeSince
Chief Executive Officer 67 -
Corporate Officer/Principal 82 31/12/81
Director/Board Member 61 31/12/99
More insiders
Date Price Change Volume
22/05/24 87,400 +0.34% 3,554
21/05/24 87,100 +0.11% 1,679
20/05/24 87,000 +7.41% 11,826
17/05/24 81,000 +1.25% 1,300
16/05/24 80,000 0.00% 204

End-of-day quote HANOI S.E., May 21, 2024

More quotes
Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based company principally engaged in the manufacturing and distributing of pharmaceutical products, medicines, cosmetic and other products used in the healthcare sector. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.
More about the company